Crinetics Pharmaceuticals Inc. Revenue 2016–2025
Crinetics Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Crinetics Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 10.7 M, a 2873.41% increase year-over-year.
- Crinetics Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 12.3 M, a 785.85% increase year-over-year.
- Crinetics Pharmaceuticals Inc. annual revenue for 2025 was 7.7 M, a 640.71% increase from 2024.
- Crinetics Pharmaceuticals Inc. annual revenue for 2024 was 1.0 M, a 74.11% decrease from 2023.
- Crinetics Pharmaceuticals Inc. annual revenue for 2023 was 4.0 M.
- Crinetics Pharmaceuticals Inc. annual revenue for 2022 was 0.
Crinetics Pharmaceuticals Inc. (CRNX) — Frequently Asked Questions
Crinetics Pharmaceuticals Inc. (CRNX) is a publicly traded US company. It has a market capitalization of $3.11B. In fiscal 2025 it reported revenue of $8M and net income of -$465M. Explore CRNX's stock price, financial statements, earnings history, margins and key ratios below.
What is Crinetics Pharmaceuticals Inc.'s market cap?
Crinetics Pharmaceuticals Inc. (CRNX) has a market capitalization of $3.11B.
What is the CRNX stock price?
CRNX trades at $33.09 (-3.57% on the day).
How much revenue does Crinetics Pharmaceuticals Inc. make?
Crinetics Pharmaceuticals Inc. reported revenue of $8M in fiscal 2025.
Is CRNX profitable?
In fiscal 2025, Crinetics Pharmaceuticals Inc. reported net income of -$465M.